Mainz Biomed N.V. (QUCY) Stock Analysis & Investment Frameworks
Mainz Biomed N.V. (QUCY) stock analysis on Invetso. Review Mainz Biomed N.V.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Mainz Biomed N.V. Company Overview
- Exchange: NASDAQ Global Market
- Sector: Healthcare
- Industry: Medical - Diagnostics & Research
- Country: DE
Mainz Biomed N.V. Key Financial Metrics
- Market Cap: $24.36M
- Revenue: $537080.00
- ROE: -365.38%
- ROIC: -99.36%
- Dividend Yield: N/A
About Mainz Biomed N.V.
Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies. It also develops platforms that integrate artificial intelligence (AI) and quantum computing technologies for autonomous control systems used in unmanned aerial, ground, and underwater vehicles, including drones, self-driving vehicles, and robotic fleets. Quantum Cyber N.V. was formerly known as Mainz Biomed N.V. and changed its name to Quantum Cyber N.V. in April 2026. The company is headquartered in Mainz, Germany.
Mainz Biomed N.V. Investment Frameworks
Invetso analyzes Mainz Biomed N.V. (QUCY) across the following frameworks:
- Mainz Biomed N.V. 10Y Growth Potential
- Mainz Biomed N.V. Scenario Analysis
- Mainz Biomed N.V. Risks & Opportunities
- Mainz Biomed N.V. Economic Moat
- Mainz Biomed N.V. Business Model
- Mainz Biomed N.V. Management
- Mainz Biomed N.V. SWOT Analysis
- Mainz Biomed N.V. Porter's 5 Forces
- Mainz Biomed N.V. PESTLE Analysis
- Mainz Biomed N.V. ESG Analysis